Researchers create random versions of human genomes to study disease

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.

Illumina chief commercial officer leaves to lead liquid biopsy startup Delfi

Delfi Diagnostics, a startup devising new ways to use routine blood draws to detect early signs of cancer, told STAT Thursday that it has appointed

January 5, 2024

M&A: Avel eCare acquires Horizon Virtual

What You Should Know: – Avel eCare, the nation’s leading provider of clinician-to-clinician telemedicine services, continues its aggressive growth strategy with the acquisition of Horizon

May 2, 2024

BrainStorm withdraws ALS drug application after negative adcomm vote

BrainStorm Cell Therapeutics is pulling its application for a controversial ALS drug a few weeks after a group of outside experts said the drug likely

October 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.